These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 938701)

  • 1. Vitamins, neuroleptics, and antiparkinsonian drugs in catecholamine excretion.
    Yaryura-Tobias JA; Fledel T; Neziroglu F
    Biol Psychiatry; 1976 Jun; 11(3):363-6. PubMed ID: 938701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
    Caroli F; Littre-Poirier MF; Ginestet D; Deniker P
    Encephale; 1975; 1(1):69-74. PubMed ID: 805695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of psychotropic drug use for schizophrenia.
    Laska E; Varga E; Wanderling J; Simpson G; Logemann GW; Shah BK
    Dis Nerv Syst; 1973; 34(6):294-305. PubMed ID: 4782286
    [No Abstract]   [Full Text] [Related]  

  • 5. Basic principles of rapid neuroleptization.
    Mason AS; Granacher RP
    Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroleptics in the treatment of psychoses].
    Sedvall G
    Lakartidningen; 1972 Mar; 69():78-84. PubMed ID: 4664128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic problems in the application of antiparkinsonian drugs in psychiatry].
    Piasecki T
    Psychiatr Pol; 1996; 30(1):137-50. PubMed ID: 8722246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
    Manos N; Lavrentiadis G; Gkiouzepas J
    J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.
    Voorhess ML
    Pediatrics; 1967 Feb; 39(2):252-7. PubMed ID: 6017961
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal of antiparkinson drugs.
    Orlov P; Kasparian G; DiMascio A; Cole JO
    Arch Gen Psychiatry; 1971 Nov; 25(5):410-2. PubMed ID: 5133814
    [No Abstract]   [Full Text] [Related]  

  • 12. [Excretion of catecholamines in patients with obliterating arteriosis before and after complex conservative treatment].
    Mikeladze NA
    Klin Khir (1962); 1974 Jul; 7(0):21-5. PubMed ID: 4848703
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of aminazine on the excretion of adrenaline noradrenaline, dopamine and dopa in healthy subjects and in the manic phase of manic-depressive psychosis].
    Matlina ESh; Osipova MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):128-31. PubMed ID: 5448719
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptics, catecholamines, and psychoses: a study of their interrelations.
    Van Praag HM; Korf J
    Am J Psychiatry; 1975 Jun; 132(6):593-7. PubMed ID: 235848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.
    Okada T; Toichi M; Sakihama M
    J Clin Psychopharmacol; 2003 Oct; 23(5):441-7. PubMed ID: 14520119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of vitamins C, B 1 and B 6 on the functional state of the sympatho-adrenal system in atherosclerotic cardiosclerosis].
    Zaretskiĭ MM; Vakhtina TI
    Vopr Pitan; 1971; 30(6):20-3. PubMed ID: 5131656
    [No Abstract]   [Full Text] [Related]  

  • 17. The use and abuse of the psychotropic drugs.
    Enelow AJ
    J Okla State Med Assoc; 1973 Aug; 66(8):355-9. PubMed ID: 4584731
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of schizophrenia with special reference to megavitamin therapy.
    Ban TA
    Can J Psychiatr Nurs; 1973; 14(2):6-9. PubMed ID: 4489177
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical clinical psychopharmacology: the tranquilizers.
    Snodgrass RE
    J Indiana State Med Assoc; 1975 Oct; 68(10):883-7. PubMed ID: 1194695
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.